目的 探究单孔腹腔镜胆囊切除术（LC）治疗胆囊结石（GD）患者的效果。方法 回顾性收集2021年1月—2023年9月郑州大学附属郑州中心医院收治的96例GD患者病例资料,按手术方案不同分两组。以接受单孔LC治疗的48例患者列为A组,以接受三孔LC治疗的48例患者列为B组。对比两组围术期指标、手术前后胃肠激素指标[胃泌素（GAS）、胃动素（MTL）]、肝功能指标[天门冬氨酸转氨酶（AST）、丙氨酸氨基转移酶（ALT）]、疼痛介质指标[前列腺素E2（PGE-2）、5-羟色胺（5-HT）]水平、术后并发症发生率。结果 A组手术用时（71.56±6.29）min更长于B组（62.37±5.85）min,术后排气时间（15.37±2.26）h、住院用时（5.30±1.24）d、切口总长度（1.84±0.27）cm短于B组（17.49±3.55）h、（7.64±1.35）d、（4.13±0.35）cm,术中失血量（41.28±4.36）mL低于B组（58.31±6.52）mL更低（均P<0.001）;术后1 d A组GAS（113.34±13.47）pg/mL、MTL（202.78±24.68）pg/mL水平高于B组（102.65±11.08）pg/mL、（164.34±20.76）pg/mL（均P<0.001）;术后1d A组AST（31.82±3.62）U/L、ALT（40.36±4.74）U/L水平低于B组（38.78±4.03）U/L、（51.60±5.42）U/L（均P<0.001）;术后1 d A组SP（55.84±5.90）ng/L、5-HT（132.17±9.16）ng/mL、PGE-2（25.45±4.27）ng/mL水平低于B组（73.27±7.51）ng/L、（173.54±13.32）ng/mL、（31.71±5.24）ng/mL（均P<0.001）;A组并发症发生率2.08%（1/48）低于B组16.67%（8/48）更低。结论 与三孔LC治疗GD患者相比,经单孔LC治疗会略微延长手术用时,但能进一步减少术中失血量,降低术后并发症风险,缩短切口长度及患者康复进程,且对机体胃肠功能、肝功能影响更小,对机体造成疼痛应激更轻微,更符合微创特征。

Objective To explore the effect of single-incision laparoscopic cholecystectomy（LC）in the treatment of patients with gallstone disease（GD）．Methods Retrospective data of 96 GD patients in Zhengzhou Central Hospital Affiliated to Zhengzhou University（January 2021—September 2023）were collected and divided into two groups according to different surgical protocols．Forty-eight patients receiving single-incision LC were classified as group A,and 48 patients receiving three-port LC were classified as group B．The perioperative indexes,gastrointestinal hormone indexes[gastrin（GAS）,motilin（MTL）],liver function indexes[aspartate aminotransferase（AST）,alanine aminotransferase（ALT）],pain mediator indexes[prostaglandin E2（PGE-2）,5-hydroxytryptamine（5-HT）] before and after operation,and the incidence of postoperative complications were compared between the two groups．Results The operation time in group A was（71.56±6.29）min,which was longer than that in group B（62.37±5.85）min．In group A,the postoperative exhaust time was（15.37±2.26）h,hospitalization time was（5.30±1.24）d,and the total length of incision was（1.84±0.27）cm,which were shorter than those in group B[（17.49±3.55）h,（7.64±1.35）d,and（4.13±0.35）cm]．The intraoperative blood loss was（41.28±4.36）mL,which were lower than（58.31±6.52）mL in group B（all P<0.001）．The levels of GAS[（113.34±13.47）pg/mL] and MTL[（202.78±24.68）pg/mL] in group A were higher than those in group B[（102.65±11.08）pg/mL and（164.34±20.76）pg/mL]（all P<0.001）．The levels of AST[（31.82±3.62）U/L] and ALT[（40.36±4.74）U/L] in group A were lower than those in group B[（38.78±4.03）U/L and（51.60±5.42）U/L]（all P<0.001）．The levels of SP[（55.84±5.90）ng/L],5-HT[（132.17±9.16）ng/mL],pge-2[（25.45±4.27）ng/mL] in group A were lower than those in group B[（73.27±7.51）ng/L,（173.54±13.32）ng/mL and （31.71±5.24）ng/mL]（all P<0.001）．The incidence of complications in group A was 2.08%（1/48）,which was lower than that in group B[16.67%（8/48）]（χ²=4.414,P=0.036）．Conclusion sCompared with three-port LC for GD patients,single-incision LC can slightly prolong the operation time,but it can further reduce the intraoperative blood loss,reduce the risk of postoperative complications,shorten the incision length and the rehabilitation process of patients,and has less impact on the gastrointestinal function and liver function,causing less pain stress to the body,which is more in line with the characteristics of minimally invasive．

目的 探析慢性阻塞性肺疾病急性加重（AECOPD）患者在全身糖皮质激素（激素）使用过程中检测呼出气一氧化氮（FeNO）的价值。方法 于2019年1月—2021年12月梅州市人民医院采集病例展开随机对照研究,实施对象为58例AECOPD患者,均检测FeNO水平,根据FeNO水平是否>25 ppb,分组为FeNO高水平组和FeNO低水平组,根据是否接受全身激素治疗分为治疗组和对照组,对照组予以常规治疗,治疗组实行常规+全身激素治疗;检测治疗前后FeNO、肺功能指标水平变化,判定COPD评估测试（CAT）评分,对比组间差异。结果 FeNO高水平组全身激素治疗后（治疗组）FeNO降低（P<0.05）,高水平组常规治疗后（对照组）FeNO前后比较差异无统计学意义（P>0.05）,低水平组中治疗组和对照组治疗前后FeNO比较差异无统计学意义（P>0.05）;FeNO高水平组治疗后第一秒用力呼气容积（FEV₁）、第一秒用力呼气量占用力肺活量比值（FEV₁/FVC）均升高,且治疗组升高程度较对照组更大（均P<0.05）,FeNO低水平组治疗后FEV₁、FEV₁/FVC均升高（均P<0.05）,但治疗组与对照组相比无差异（P>0.05）;FeNO高水平组、低水平组治疗后CAT评分较治疗前均下降（均P<0.05）,FeNO高水平组下降更明显。结论 AECOPD患者实施FeNO测定,其水平变化在一定程度上可反映气道炎症,并预测激素治疗反应,指导合理有效地应用全身激素,避免出现激素过度使用情况。

Objective To explore the value of detecting exhaled nitric oxide(FeNO)during systemic glucocorticoid use in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods A randomized controlled study was conducted from January 2019 to December 2021 at the People's Hospital of Meizhou City. The subjects were 58 AECOPD patients,all of whom were tested for FeNO levels. Based on whether the FeNO levels were>25 ppb,they were divided into a high level FeNO group and a low level FeNO group. They were divided into a treatment group and a control group based on whether they received systemic glucocorticoid therapy. The control group received routine treatment,while the treatment group received routine and systemic glucocorticoid therapy. Changes in FeNO and lung function indicators before and after treatment were detected,COPD assessment test(CAT)scores were determined,and differences between groups were compared. Results After systemic glucocorticoid therapy,the high level group of FeNO showed a decrease in FeNO(P<0. 05),while the high level group showed no statistically significant difference in FeNO before and after routine treatment(P>0. 05). The low level group showed no statistically significant difference in FeNO between the treatment group and the control group before and after treatment(P>0. 05). The first second forced expiratory volume(FEV₁)and the ratio of first second forced expiratory volume to forced vital capacity(FEV₁/FVC)in the high level group of FeNO significantly increased after treatment,and the degree of increase in the treatment group was greater than that in the control group(all P<0. 05). The FEV₁ and FEV₁/FVC in low level group of FeNO significantly increased after treatment(all P<0. 05),but the difference between the treatment group and the control group was not significant(P>0. 05). The CAT scores of the high and low levels of FeNO groups decreased after treatment compared to before treatment(all P<0. 05),and the decrease was more significant in the high level FeNO group. Conclusions The implementation of FeNO measurement in AECOPD patients can reflect airway inflammation to a certain extent,predict glucocorticoid treatment response,guide the rational and effective application of systemic glucocorticoid and avoid excessive glucocorticoid use.

目的 研究结核感染T细胞斑点试验(T-SPOT.TB)技术联合胸水腺苷脱氨酶(ADA)在结核性胸膜炎中的诊断价值。方法 在研究中选取2016年1月—2018年12月在梅州市人民医院呼吸内科和全科医学科住院的60例结核性胸膜炎患者作为研究对象,对所有患者均进行血T-SPOT.TB、胸水ADA检查,比较血T-SPOT.TB、胸水ADA及胸水ADA联合血T-SPOT.TB检查三种检测方式的诊断符合率、误诊率、漏诊率、阳性预测值、阴性预测值、准确性、特异度、敏感度。结果 胸水ADA、血T-SPOT.TB以及血T-SPOT.TB联合胸水ADA检测方式的诊断符合率分别为75%、80.00%、93.33%,联合检测方式的诊断符合率高于单一检测方式的诊断符合率(P＜0.05)。血T-SPOT.TB联合胸水ADA检测方式的误诊率、漏诊率分别为0.00%、1.72%,低于胸水ADA、T-SPOT.TB检测方式(P＜0.05);血T-SPOT.TB联合胸水ADA检测方式的阳性预测值、阴性预测值分别为100.00%,67.78%,联合检测方式的阴性预测值高于其单一检测方式(P＜0.05)。T-SPOT.TB联合胸水ADA检测方式的特异度及敏感度分别为98.79%、97.87%,联合检测方式的敏感度高于其单一检测方式(P＜0.05)。血T-SPOT.TB检测方式与胸水ADA检测方式仅在特异度方面不存在统计学差异(P＞0.05)。结论 在对结核性胸膜炎患者进行诊断时,血T-SPOT.TB联合胸水ADA具有较高的诊断价值,值得应用。

Objective To investigate the diagnostic value of t-spot test (T-SPOT.TB) combined with adenosine deaminase (ADA) in tuberculous pleuritis. Methods 60 patients with tuberculous pleurisy hospitalized in the departments of respiratory medicine and general practice of Meizhou People's Hospital between January 2016 and December 2018 were enrolled in the study. All the patients were examined by blood T-SPOT.TB and ADA. The diagnostic coincidence rate, false positive rate,false negative rate, positive predictive value, negative predictive value, accuracy, specificity and sensitivity of the three detection methods of T-SPOT.TB, ADA, and T-SPOT.TB combined with ADA were also analyzed. Results The diagnostic coincidence rate of ADA, T-SPOT.TB and T-SPOT.TB combined with ADA was 75%, 80.00% and 93.33%, respectively. The diagnostic coincidence rate of the combined test was higher than that of the detection method (P<0.05). The misdiagnosis rate and missed diagnosis rate of blood T-SPOT.TB combined with ADA were 33.3% and 1.75%, respectively. The positive predictive value and negative predictive value of blood T-SPOT.TB combined with ADA test were 98.2% and 66.6%, respectively. The negative predictive value of combined T-SPOT.TB combined with ADA test was higher than that of the single test (P<0.05). The specificity and sensitivity of the T-SPOT.TB combined with ADA were 98.79% and 97.87%, respectively, and the sensitivity of the combined test was higher than that of the single test (P<0.05). Conclusion Blood T-SPOT.TB combined with pleural effusion ADA has higher diagnostic value in patients with tuberculous pleurisy and is worthy of clinical application.

目的 探讨口服小剂量罗红霉素联合桉柠蒎肠溶软胶囊治疗慢性鼻窦炎的疗效。方法 将96例慢性鼻窦炎患者随机分为治疗组和对照组,每组48人,对照组给予口服小剂量罗红霉素片 150 mg,2次/天,治疗组在口服相同剂量罗红霉素的基础上加用桉柠蒎肠溶软胶囊胶囊300 mg,2次/天。治疗1个月与3个月后两组疗效进行比较。结果 1个月和3个月后治疗组疗效优于对照组,两组之间差异有统计学意义(P＜0.05 )。结论 小剂量罗红霉素联合桉柠蒎肠溶软胶囊治疗慢性鼻窦炎临床效果显著,且用药方便,值得向基层医院推广。

Objective To observe the effect of eucalyptol limonene and pineneELP enteric soft capsule combined with roxithromycin on chronic sinusitis in clinical treatment. Methods 96 patients with chronic sinusitis were randomly divided into two groups: 48 cases were treated with roxithromycin(150 mg twice a day),and 48 cases were treated with roxithromycin combined with ELP enteric soft capsule (300 mg twice a day). The symptoms of patients were evaluated after 1 and 3 months treatment. Results The difference was significant between the group treated with ELP enteric soft capsule combined with roxithromycin and the group treated with roxithromycin alone after 1 month and 3 months (P＜0.05). Conclusion ELP enteric soft capsule combined with roxithromycin treating chronic sinusitis not only has evident clinical effect,but also is easy,which is worth recommending to the primary hospital.

目的 探讨分析白带涂片多功能染色技术(BTR 法)在妇科疾病患者中的临床应用价值。方法 选取300 例有明显感染症状的妇科疾病患者取白带,采用BTR 法、盐水法和巴氏染色法进行检测。结果 BTR 法病原体阳性率:滴虫42%、霉菌36.7%、线索细胞17.3%、纤毛菌12%、淋球菌6.7%、球杆菌86%、核异质细胞6.3%和癌细胞2.7%,阴道清洁度95%;阳性率高于盐水法和巴氏染色法,差异有统计学意义(P<0.01);而且BTR法操作简单,耗时少,检出率高,成本低,优于盐水法和巴氏染色法,差异有统计学意义(P<0.01)。结论 BTR 法可在几分钟内检出滴虫性或霉菌性或细菌性阴道炎、宫颈炎、宫颈癌、卵巢癌等异常情况,可提高妇科疾病病原体的检出率,为诊断和治疗提供可靠依据,适用于大型妇科普查和癌症筛查,值得在基层医院推广应用。

Objective To explore and analysis the application of leucorrhea smear multi-function BTR staining techniques(method) in gynecological disease. Methods Leucorrhea were taken in 300 gynecological disease patients with obvious infection symptoms, BTR, saline smear, pap staining were performed at the same sample. Results Pathogene positive rate ofBTR method of trichomonad, mould, clue cell, leptotrichia, gonococci, coccobacillus, dyskaryotic cell, cancer cell and vaginal cleanliness detection rate is 42%,36.7%,17.3%,12%,6.7%,86%,6.3%,2.7% and 95% respectively. The pathogens detection rate of BTR was higher than saline smear, pap staining. It showed statistical difference(P<0.01). BTR method operated simply, timely, low cost, positively than saline smear, pap staining,it showed statistical difference(P<0.01). Conclusion BTR method can detect bacterial vaginitis, colpitis mycotica, cervicitis, cervical carcinoma and ovarian cancer. It can provide reliable evidence for gynecological disease diagnosis and treatment. It can be applied in big gynecological and cancer screening. BTR method is deserved to popularize and apply in primary hospital.